Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...
Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback